Dr. Andrew Thomas Coxon, MD

  • MO
  • Neurosurgeon
NPI1437889664
Part D claims, 2024
91
Publications
10
Clinical trials
1
Industry payments
$873
State license
1
Practice address
MO
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Find Dr. Coxon's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Andrew Thomas Coxon is a neurosurgeon in Missouri

Dr. Coxon practices in Missouri.

Dr. Coxon's NPI, 1437889664, was assigned on June 11, 2022. Dr. Coxon holds Missouri license 2023023768.

NPI and contact details
NPI enumeration date
June 11, 2022
NPI status
Active
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male

Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data

Dmand AI tracks the EHR system at Dr. Andrew Thomas Coxon's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Coxon practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Dr. Coxon's practiceAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Coxon practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Andrew Thomas Coxon is one of 173 neurosurgeons in Missouri

Neurological surgery is Dr. Coxon's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Coxon is licensed in Missouri.

Specialties and state licenses

  • Neurological surgery, MissouriPrimaryLicense 2023023768 · taxonomy 207T00000X

Neurosurgeons near Dr. Coxon

Counts of neurosurgeons with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Andrew Thomas Coxon's patients have a median age of 59

Across all payers, Dmand AI patient panel data puts Dr. Coxon's median patient age at 59, with 0% women.

Dr. Coxon's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 59

Patient panel by sex, all payers

  • Women0%
  • Men100%

Source: Dmand AI Patient Panel Data

Dr. Andrew Thomas Coxon wrote 91 Medicare Part D claims in 2024

In 2024, Dr. Coxon wrote 91 Medicare Part D claims for 78 patients. 98% of them were for generic drugs. CMS names the drug for 67 of them, across 1 drug with 11 or more claims each, at $448 in total drug cost. In 2023, CMS named 16 claims across 1 drug.

Part D claims, 202491
Drugs named by CMS1
Total drug cost$448
Part D patients78

Dr. Coxon's Part D claims by kind of drug, 2024

  • Generic89 claims98%
  • Brand-name and other2 claims2%

Dr. Coxon's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Coxon's Part D claims, 2024

  • Opioids86%78 of 91 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 162024: 67319%

Drugs named by CMS: 1 in 2024, 1 in 2023.

See all prescribing by Dr. Coxon

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

For MedTech and pharma teams

Find neurosurgeons like Dr. Coxon by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Andrew Thomas Coxon has 10 publications on record

Dmand AI links 10 papers to Dr. Coxon, published from 2021 to 2025. 2023 was the busiest year, with 2. The most frequent topics are Brain Neoplasms, Glioblastoma and CD8-Positive T-Lymphocytes. Dr. Coxon has published most often in J Immunother Cancer. Dr. Coxon's most frequent co-authors are Gavin Peter Dunn, MD, PhD, Eric Claude Leuthardt, MD and Rupen Rajesh Desai, MD.

Papers10
Years published2021 to 2025

Dr. Coxon's papers by year, 2021 to 2025

Topics Dr. Coxon writes about most

  • Brain Neoplasms
  • Glioblastoma
  • CD8-Positive T-Lymphocytes
  • Immunotherapy
  • Tumor Microenvironment

Dr. Coxon's most frequent co-authors

Recent publications by Dr. Coxon

See all 10 publications and co-authors

See who Dr. Coxon researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Coxon works with, so you can find a warm path to the right neurosurgeons.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Andrew Thomas Coxon has worked on 1 clinical trial

Dmand AI links Dr. Coxon to 1 clinical trial. Conditions studied include Central Nervous System Neoplasms and Nervous System Neoplasms.

Conditions in Dr. Coxon's trials

  • Central Nervous System Neoplasms
  • Nervous System Neoplasms

Investigators on the most trials with Dr. Coxon

Recent clinical trials with Dr. Coxon

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Andrew Thomas Coxon received $873 in industry payments from 2023 to 2025

CMS Open Payments shows 8 general payments to Dr. Coxon from 5 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 52% of the total. Stryker Corporation paid the most, $587.

General payments to Dr. Coxon by program year, 2023 to 2025

General payments to Dr. Coxon by kind, 2023 to 2025

$873in total
  • Food and beverage$45852%
  • Education$41548%

Companies that paid Dr. Coxon the most, 2023 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Coxon

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Andrew Thomas Coxon's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Andrew Thomas Coxon

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Andrew Thomas Coxon's NPI number?

Dr. Andrew Thomas Coxon's NPI number is 1437889664. It was assigned on June 11, 2022, and it is active in the NPI Registry.

What kind of doctor is Dr. Andrew Thomas Coxon?

Dr. Andrew Thomas Coxon is a neurosurgeon in Missouri. The primary specialty in the NPI Registry is Neurological Surgery Physician (taxonomy code 207T00000X).

What is Dr. Andrew Thomas Coxon's medical license number?

Dr. Coxon holds Missouri license 2023023768.

What drugs does Dr. Andrew Thomas Coxon prescribe most?

In 2024 Medicare Part D data, Dr. Coxon's most prescribed drugs by claims were Oxycodone HCl.

Has Dr. Andrew Thomas Coxon received payments from drug or device companies?

CMS Open Payments shows $873 in general payments to Dr. Coxon from 5 companies from 2023 to 2025. The largest total came from Stryker Corporation.

How long has Dr. Andrew Thomas Coxon been practicing?

Dr. Coxon's NPI was assigned in 2022.

Does Dr. Andrew Thomas Coxon do research?

Dmand AI links 10 publications to Dr. Coxon, published from 2021 to 2025. Dr. Coxon has worked on 1 clinical trial.

Who does Dr. Andrew Thomas Coxon publish with?

Dr. Coxon's most frequent co-authors are Gavin Peter Dunn, MD, PhD (6 shared papers), Eric Claude Leuthardt, MD (5 shared papers) and Rupen Rajesh Desai, MD (4 shared papers).

Selling to neurological surgery practices?

See neurosurgeons in Missouri by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)